66628-1-Ig

antibody from Proteintech Group

Targeting: ACTN4 FSGS1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

66628-1-Ig

Provider

Proteintech Group

Product name

ACTN4 antibody

Antibody type

Monoclonal

Description

KD/KO validated ACTN4 antibody (Cat. #66628-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Mouse, Rat and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1E12B8

Vial size

20ul, 150ul

References

Submitted references

The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway.

Liu P, Liu S, Zhu C, Li Y, Li Y, Fei X, Hou J, Wang X, Pan Y
Frontiers in oncology 2023;13:1169833

---

TRIP13 exerts a cancer-promoting role in cervical cancer by enhancing Wnt/β-catenin signaling via ACTN4.

Liu X, Shen X, Zhang J
Environmental toxicology 2021 Sep;36(9):1829-1840

---

1β-Hydroxyalantolactone from Inulae Flos alleviated the progression of pulmonary fibrosis via inhibiting JNK/FOXO1/NF-κB pathway.

Yu B, Jin XQ, Yu WY, Dong YY, Ying HZ, Yu CH
International immunopharmacology 2021 Dec;101(Pt A):108339

---

Dysregulated expression of ACTN4 contributes to endothelial cell injury via the activation of the p38-MAPK/p53 apoptosis pathway in preeclampsia.

Zhao J, Peng W, Ran Y, Ge H, Zhang C, Zou H, Ding Y, Qi H
Journal of physiology and biochemistry 2019 Nov;75(4):475-487